达仁堂股价下跌1.65% 半年报营收下滑33.15%

Core Viewpoint - The stock price of Darentang is reported at 45.77 yuan, reflecting a decline of 1.65% from the previous trading day, with a trading volume of 6.98 billion yuan [1] Group 1: Company Overview - Darentang primarily engages in the production and sales of traditional Chinese medicine and Western medicine, owning several well-known brands such as Darentang and Longshunrong [1] - The company's core products include traditional Chinese medicine varieties like Su Xiao Jiu Xin Wan and Qing Yan Di Wan [1] Group 2: Financial Performance - In the first half of 2025, the company's operating revenue decreased by 33.15% to 2.651 billion yuan [1] - Revenue from traditional Chinese medicine business was 2.425 billion yuan, down 20.81% year-on-year, while revenue from Western medicine business was 468 million yuan, down 24.86% year-on-year [1] - The net profit attributable to the parent company was 1.928 billion yuan, an increase of 193.08% year-on-year, but the non-recurring net profit decreased by 5.93% to 596 million yuan [1]